Respiratory specialist leaders criticised for financial entanglements with industry

Extensive financial links between the leaders of US respiratory specialist associations and the pharmaceutical and medical device industries have raised concerns over independence and integrity. More than A$5.3 million (US$3.6m) in industry payments flowed to leaders of the American Thoracic Society (ATS) over a five year period according to figures published in BMJ. But respiratory ...